Pure Global AI
ANVISA registration 80944340014Active

GLYCATED HEMOGLOBIN (HbA1C)

ANVISA Registration Number: 80944340014TRINITY BIOTECH DO BRASIL COMÉRCIO E IMPORTAÇÃO LTDA.TRINITY BIOTECHRisk Class II
Device names
Technical name
GLYCATED HEMOGLOBIN (HbA1C)
PT: HEMOGLOBINA GLICADA (HbA1C)
Commercial name
Tri-stat Reagent Kit
Risk class
Class II
Registration details
Registration Number
80944340014
Process Number
25351655806201818
CNPJ
15648426000123
Company information
Manufacturer
TRINITY BIOTECH
Manufacturing Country
United States
PT: ESTADOS UNIDOS DA AMÉRICA
Dates and status
Publication Date
Feb 18, 2019
Status
Active
Official value: VIGENTE
About this record

Access comprehensive regulatory information for GLYCATED HEMOGLOBIN (HbA1C) in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80944340014 and manufactured by TRINITY BIOTECH. The registration is held by TRINITY BIOTECH DO BRASIL COMÉRCIO E IMPORTAÇÃO LTDA. with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.